Other work has shown that T-FUS increases the population of CD8+ T cells and reduces regulatory T (Treg) cells within the tumor (42), while also enriching the number of dendritic cells (DCs) in the tumor-draining lymph nodes (TDLNs). The gene discussed is CD8A; the disease is neoplasm.